MTRC has released European reimbursement report for percutaneous interventions for deep vein thrombosis

Report provides overview of procedure coding, payment mechanism, reimbursement tariffs and policy considerations for key percutaneous treatment methods, including:

• mechanical and pharmacomechanical (AngioJet, Boston Scientific) thrombectomy,
• catheter-directed and ultrasound-enhanced catheter-directed (EKOS, BTG) thrombolysis.

Analysis is provided for 11 European countries (Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland).

The following clinical situations are considered:

• Stand-alone procedure, performed as primary procedure due to admission due to deep vein thrombosis
• Procedure, performed as secondary procedure for DVT, developed during hospital admission for coronary artery bypass grafting or hip replacement
  • Analysis is performed for CABG and hip replacement
    • With no complications
    • With DVT and no interventional treatment
    • With DVT and interventional treatment

Analysis is performed only for non-elective hospital admission with at least an overnight stay.

Read more and place an order here.

Request sample pages (analysis in the UK) or schedule a call with our manager to receive more information about the report.